Results 131 to 140 of about 27,546 (256)

Establishing the Profile of Eye Diseases at Nkhatabay District Hospital, Malawi: A Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background The distribution of eye diseases differs depending on the geographical and socioeconomic context. Aim Therefore, this study analysed the pattern of eye conditions and diseases among patients at Nkhatabay District Hospital in Malawi. Methods This was a quantitative retrospective study conducted by extracting data from the outpatient ...
Mercy Gaveta   +3 more
wiley   +1 more source

A review of generic preference-based measures of health-related quality of life in visual disorders [PDF]

open access: yes
Purpose: This review examines generic preference based measures and their ability to reflect health related quality of life in patients with visual disorders.
Brazier, J.   +3 more
core  

Atopic Comorbidities Associated With Chronic Spontaneous Urticaria: A Case‐Control Analysis of the All of Us Research Program

open access: yesJEADV Clinical Practice, Volume 5, Issue 1, Page 194-197, March 2026.
ABSTRACT Background Chronic spontaneous urticaria (CSU) is a mast cell‐driven condition defined by recurrent wheals and/or angioedema lasting over 6 weeks without an identifiable trigger. Though CSU is known to co‐occur with atopic diseases and share Th2‐dominant immunologic pathways, prior studies have not adequately addressed these relationships in ...
Julian A. Cortes   +4 more
wiley   +1 more source

Fexofenadine is Efficacious and Safe in Children (Aged 6-11 Years) with Seasonal Allergic Rhinitis [PDF]

open access: yes, 2003
Background: This is the first prospective, randomized, doubleblind, placebo-controlled study showing statistical improvement of an H1-antihistamine in children with seasonal allergic rhinitis in all symptoms throughout the entire treatment period ...
Bachert, C   +12 more
core  

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

open access: yesThe Journal of Dermatology, Volume 53, Issue 3, Page 399-409, March 2026.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki   +24 more
wiley   +1 more source

Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis

open access: yesThe Journal of Dermatology, Volume 53, Issue 3, Page 410-420, March 2026.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe   +5 more
wiley   +1 more source

Treatment Patterns and Healthcare Utilization on Pediatric Atopic Dermatitis With Allergic Comorbidities: A Japanese Claims‐Based Study

open access: yesThe Journal of Dermatology, Volume 53, Issue 3, Page 437-446, March 2026.
ABSTRACT Atopic dermatitis (AD) is a chronic, itchy skin disease that often begins in infancy and may persist into adulthood. The high co‐occurrence of allergic comorbidities (ACMs; asthma, food allergy, and allergic rhinitis) makes it a growing public health concern.
Masaki Futamura   +6 more
wiley   +1 more source

Evaluation of Antiallergic Conjunctivitis Effects of Extract of Nelumbo nucifera Rhizome and Its Isolated Constituents Against Chemical-Induced Allergic Conjunctivitis in Experimental Rats

open access: yesJournal of Chemistry
Allergic conjunctivitis, an inflammation of the conjunctiva, is commonly treated with conventional drugs such as mast cell stabilizers, corticosteroids, antihistamines, NSAIDs, and others; these drugs associated lots of side effects including dryness ...
Phool Chandra   +7 more
doaj   +1 more source

Long‐Term, Site‐Specific Effectiveness of Tralokinumab in Atopic Dermatitis: A 72‐Week Real‐World Study

open access: yesThe Journal of Dermatology, Volume 53, Issue 3, Page 454-460, March 2026.
ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba   +6 more
wiley   +1 more source

Timing of Intrapartum Antibiotics at Caesarean Section and Risk of Asthma, Eczema and Allergic Rhinitis: Results From a Natural Experiment

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 698-707, March 2026.
ABSTRACT Objective To investigate whether the risk of asthma, eczema and allergic rhinitis at 5 years in children born by caesarean section (CS) differs by the timing of antibiotic administration to the mother (pre‐incision vs. post‐cord clamping). Design Natural experiment using birth cohort data. Setting UK single centre population‐based birth cohort.
Lucy Pembrey   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy